US SEC Filings Daily Market Digest — February 24, 2026

25-02-2026

25-02-2026

ANAVEX LIFE SCIENCES CORP. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

25-02-2026

Biomea Fusion, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core events, financial metrics, transactions, positive or negative performance indicators, or quantitative data are explicitly stated in the filing summary. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance with attached exhibits.

25-02-2026

LivaNova PLC filed a Form 8-K on February 25, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, margins, or period-over-period metrics are detailed in the provided filing information. No positive or negative performance indicators, guidance, or balance sheet impacts are mentioned.

25-02-2026

VisionWave Holdings, Inc. filed an 8-K on February 25, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, typically following an annual or special shareholder meeting. No specific proposals, vote outcomes, numerical results (e.g., for/against/abstain/broker non-votes), or other details are disclosed in the provided filing information. This is a routine informational disclosure with no financial or operational metrics mentioned.

25-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events, which discloses a material event not covered by other specific items. The filing also includes Item 9.01 Financial Statements and Exhibits, indicating attachments such as financial data or agreements. No specific details on the event, transaction values, financial metrics, or performance comparisons are disclosed in the provided filing summary.

25-02-2026

Taboola.com Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006649), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are available.

25-02-2026

Clear Secure, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results without detailed quantitative data.

25-02-2026

Dole plc filed a Form 8-K on 2026-02-25 (AccNo: 0001857475-26-000014, Size: 1 MB) disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary filing typical for earnings releases. No specific financial metrics, period-over-period comparisons, guidance, or performance details (positive, negative, or flat) are disclosed in the provided filing information.

25-02-2026

Battalion Oil Corp filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 includes financial statements and exhibits, likely pro forma financials related to the transaction. No specific details on deal structure, parties, valuation, synergies, or quantitative metrics are disclosed in the provided filing information.

25-02-2026

WESCO INTERNATIONAL INC filed an 8-K on February 25, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the nature of the exhibits are disclosed. No financial metrics, transactions, or performance data are provided.

25-02-2026

Archrock, Inc. filed an 8-K on 2026-02-25 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results with no specific revenue, earnings, guidance, or other metrics provided in the filing information. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are disclosed.

25-02-2026

The company filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019327) under Item 5.02 disclosing an officer change event dated February 25, 2026. No specific details regarding the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment or resignation), reason, or timing are disclosed. This filing provides no quantitative data, financial metrics, or further context on governance implications.

25-02-2026

Verses AI Inc. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.

25-02-2026

Ashford Hospitality Trust Inc filed an 8-K on 2026-02-25 under Item 5.02 disclosing potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. No specific names, positions affected, reasons for changes, timing, or other details are disclosed. This filing provides informational disclosure on leadership and governance matters without quantified financial impacts or directional bias.

25-02-2026

Luminar Technologies, Inc./DE filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are explicitly stated in the provided filing information. The disclosure appears informational with attached exhibits, but core content is NOT_DISCLOSED.

25-02-2026

Avista Corp filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item filing for financial results announcement. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing details.

• ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
• ·Accession Number: 0001193125-26-067873
• ·Filing size: 8 MB

25-02-2026

LifeStance Health Group, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including key position, appointment or resignation, reasons, or timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

25-02-2026

TALOS ENERGY INC. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-067747, Size: 1 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other quantitative metrics. No positive or negative performance indicators, guidance, or comparisons are detailed in the filing description.

25-02-2026

Arcosa, Inc. filed a Form 8-K on February 25, 2026, disclosing entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, financial metrics, transaction values, or performance comparisons are provided in the filing summary. This multi-item filing indicates potentially significant developments, but lacks quantitative data or directional indicators.

25-02-2026

News Corp filed a Form 8-K on February 25, 2026 (AccNo: 0001564708-26-000041), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing summary. This appears to be a multi-item, voluntary disclosure under Item 8.01 with required exhibit listing.

25-02-2026

25-02-2026

Hippo Holdings Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified details.

25-02-2026

Postal Realty Trust, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011279, Size: 377 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This multi-item filing is a standard voluntary disclosure for earnings releases. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing details.

25-02-2026

Hyliion Holdings Corp. filed an 8-K on 2026-02-25 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are detailed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.

25-02-2026

FLUSHING FINANCIAL CORP filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided in the filing summary. No positive or negative metrics, changes, or impacts are mentioned.

25-02-2026

Kosmos Energy Ltd. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

25-02-2026

Blackstone Secured Lending Fund filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or quantitative financial metrics are disclosed in the provided filing details. This is an informational earnings-related disclosure with no directional financial data available.

• ·AccNo: 0001213900-26-020083
• ·Filing size: 30 MB
• ·Sector: not specified
• ·Critical missing information: All financial metrics (revenue, earnings, margins, YoY/QoQ changes), guidance, balance sheet details, scheduled events (earnings calls), insider activity, and specific results of operations; data completeness LOW (<50%)

25-02-2026

Shoe Carnival Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed in the provided information. No quantitative data or directional indicators provided.

25-02-2026

OZOP Energy Solutions, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-007952, Size: 192 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, quantitative data, or other details are explicitly stated in the provided filing information. Sector is not specified.

25-02-2026

Circle Internet Group, Inc. filed a Form 8-K on 2026-02-25 reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No period-over-period comparisons, balance sheet effects, or outlook revisions are provided in the filing summary.

25-02-2026

UnitedHealth Group Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, or other metrics are mentioned.

• ·AccNo: 0000731766-26-000046
• ·File size: 189 KB
• ·Event date: 2026-02-25
• ·Sector: NOT_DISCLOSED

25-02-2026

Owens Corning filed an 8-K on February 25, 2026 (AccNo: 0001370946-26-000066), reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

25-02-2026

UNITED THERAPEUTICS Corp filed a Form 8-K on February 25, 2026 (AccNo: 0001082554-26-000007, Size: 536 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard earnings-related disclosure for a US biotech/pharma company, but no specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

• ·File size: 536 KB

25-02-2026

Broadstone Net Lease, Inc. filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or quantitative data are disclosed in the filing summary provided. This appears to be a voluntary disclosure of material non-public information with attached exhibits, but details are NOT_DISCLOSED.

25-02-2026

AMC Entertainment Holdings, Inc. filed an 8-K on February 25, 2026, under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative data extracted.

25-02-2026

Bloomin' Brands, Inc. filed a Form 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

25-02-2026

Recursion Pharmaceuticals, Inc. filed an 8-K on February 25, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other metrics. No period-over-period comparisons, guidance, or directional performance indicators (positive, negative, or flat) are mentioned.

25-02-2026

Alexander & Baldwin, Inc. filed a Form 8-K on February 25, 2026, specifically under Item 8.01 Other Events. No details on the core event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This appears to be a single-item filing with no quantitative data or period-over-period comparisons mentioned.

25-02-2026

Aspen Aerogels Inc filed an 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.

25-02-2026

Hut 8 Corp. filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were mentioned in the filing description. This is an informational filing with all quantitative financial metrics NOT_DISCLOSED.

25-02-2026

Starwood Property Trust, Inc. filed an 8-K on February 25, 2026, under Item 2.02 announcing results of operations and financial condition. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative metrics available.

25-02-2026

O-I Glass, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.

25-02-2026

BLACKBOXSTOCKS INC. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with a change in control of the registrant (Item 5.01), unregistered sales of equity securities (Item 3.02), and material modifications to rights of security holders (Item 3.03). Governance changes include departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and amendments to the code of ethics (Item 5.05). Additional items cover Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01); no quantitative metrics, deal terms, or parties were disclosed.

25-02-2026

Acadia Healthcare Company, Inc. filed an 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.

25-02-2026

Lineage, Inc. filed an 8-K on February 25, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results on a voluntary basis. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data are provided in the filing details.

25-02-2026

Alkermes plc filed an 8-K on February 25, 2026, under Item 2.02 reporting results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified details available.

25-02-2026

BKV Corp filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings announcements, but no specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. Critical financial details such as period-over-period changes, balance sheet impacts, or outlook revisions are NOT_DISCLOSED.

• ·Multi-item 8-K filing (Items 2.02, 7.01, 9.01)
• ·AccNo: 0001628280-26-011383, File size: 895 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

Amarin Corp PLC/UK filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-068511, size 759 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector details are not specified.

25-02-2026

Hayward Holdings, Inc. filed an 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

25-02-2026

Astec Industries Inc filed a Form 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, period-over-period changes, or guidance metrics were detailed in the provided filing information. No positive or negative performance indicators, balance sheet impacts, or strategic updates were explicitly stated.

25-02-2026

Ionis Pharmaceuticals Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are explicitly stated in the provided filing details. This is a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

25-02-2026

Photronics Inc filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006717), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no directional performance indicators available.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Size: 6 MB
• ·Sector: not specified

25-02-2026

Steven Madden, Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-007955, Size: 536 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data are disclosed in the provided filing description. This appears to be a standard multi-item earnings-related disclosure with sector NOT_DISCLOSED.

25-02-2026

US Energy Corp filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. The filing size is 5 MB with Accession Number 0001437749-26-005430.

25-02-2026

Driven Brands Holdings Inc. filed an 8-K on February 25, 2026 (AccNo: 0001804745-26-000016, Size: 142 KB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific financial metrics, transactions, events, or quantitative data disclosed in the provided summary. No positive or negative performance indicators are mentioned.

25-02-2026

Dine Brands Global, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-068524), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific revenue, earnings, margins, comparisons, guidance, or other numerical metrics are disclosed in the provided information.

25-02-2026

Geron Corp filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were mentioned in the filing summary. This is a standard multi-item earnings-related disclosure with no directional financial performance data provided.

25-02-2026

Ironwood Pharmaceuticals Inc filed an 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard financial results announcement with no period-over-period comparisons or directional indicators available.

25-02-2026

Angel Oak Mortgage REIT, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are detailed in the provided information. No positive or negative performance indicators, guidance, or comparisons were mentioned.

25-02-2026

Medline Inc. filed an 8-K on February 25, 2026 (AccNo: 0002046386-26-000007, Size: 529 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with attached exhibits.

25-02-2026

Charles River Laboratories International, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011395, Size: 160 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

25-02-2026

CS Disco, Inc. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the filing description. This is a standard voluntary earnings disclosure without detailed quantitative metrics provided.

• ·Accession Number: 0001625641-26-000043
• ·File Size: 474 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

25-02-2026

DiamondRock Hospitality Co filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the affected officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

25-02-2026

HNI CORP filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics were mentioned. No positive, negative, or flat performance indicators were detailed in the provided filing information.

25-02-2026

Crane NXT, Co. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure, which typically involves voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, indicating attachments were provided. No specific details, events, transactions, financial metrics, or numerical data are disclosed in the provided filing summary. This is a multi-item filing with no information on timing relative to events or market expectations.

25-02-2026

MGP Ingredients Inc filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This multi-item filing reports financial results but no specific revenue, earnings, margins, or other quantitative metrics were detailed in the provided information. No positive or negative performance indicators, comparisons, or guidance changes were mentioned.

25-02-2026

Immunocore Holdings plc filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified metrics available.

• ·Sector not specified in filing.
• ·No details on market expectations, guidance changes, or balance sheet effects provided.

25-02-2026

Corbus Pharmaceuticals Holdings, Inc. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure, which is a voluntary release of material non-public information to ensure broad dissemination, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents such as a press release or presentation (file size 22 MB). No specific transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the filing summary. This is a multi-item, primarily voluntary disclosure with no details on timing relative to the 4-business-day requirement.

25-02-2026

APi Group Corp filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011397), furnishing Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

25-02-2026

GCT Semiconductor Holding, Inc. filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

25-02-2026

Tempest Therapeutics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-068614), reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item, likely voluntary disclosure filing with no specific core events, transactions, financial metrics, or quantitative data explicitly stated in the provided filing summary. No positive or negative performance metrics, guidance changes, or scheduled events are disclosed.

25-02-2026

Centuri Holdings, Inc. filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

25-02-2026

Atlanta Braves Holdings, Inc. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without detailed financial data available.

25-02-2026

Icahn Enterprises L.P. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the filing details provided. This appears to be a standard multi-item earnings-related disclosure without quantified metrics.

25-02-2026

Incannex Healthcare Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001213900-26-020127), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the nature of the modifications, amendments, events, or exhibits. No quantitative metrics, financial impacts, positive or negative changes, or period-over-period comparisons are disclosed.

25-02-2026

Trinity Capital Inc. filed a Form 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific quantitative metrics, period-over-period comparisons, guidance, or other performance data explicitly stated in the provided filing information. No positive or negative financial impacts are detailed.

25-02-2026

Southwest Gas Holdings, Inc. filed a Form 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure without detailed performance data.

• ·Accession Number: 0001692115-26-000060
• ·File Size: 479 KB

25-02-2026

NEWMARK GROUP, INC. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period metrics are disclosed in the provided filing information. No positive or negative financial changes can be assessed due to lack of extracted data.

25-02-2026

Empire Petroleum Corp filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the filing summary provided. No quantitative metrics, positive or negative changes, or directional performance indicators are mentioned.

25-02-2026

Pinnacle West Capital Corp filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or period-over-period metrics are provided in the filing summary. The disclosure is informational without quantified financial impacts.

25-02-2026

Wells Fargo & Company filed an 8-K on February 25, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are provided in the filing summary. This appears to be a multi-item informational filing with no quantified financial metrics, positive or negative developments explicitly stated.

25-02-2026

Tri Pointe Homes, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001561680-26-000004), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified financial metrics available.

25-02-2026

Graham Holdings Co filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons were mentioned. No positive or negative metrics were detailed.

25-02-2026

Cardiff Oncology, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068668, Size: 17 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving voluntary disclosure of potentially material non-public information with attached exhibits. No financial metrics, transactions, events, or quantitative data are specified in the filing metadata.

25-02-2026

Allurion Technologies, Inc. filed a Form 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 3.03 material modifications to rights of security holders, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, or financial impacts are disclosed. No positive or negative metrics, period-over-period comparisons, or strategic context are provided in the available information.

• ·Multi-item 8-K filing covering agreement entry, equity sales, and rights changes
• ·AccNo: 0001193125-26-068667
• ·File size: 556 KB

25-02-2026

Signing Day Sports, Inc. filed a Form 8-K on 2026-02-25 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of material non-public information with attached exhibits, but no specific details, financial metrics, transactions, or quantitative data are provided in the filing summary. No positive or negative performance indicators are mentioned.

25-02-2026

Intuitive Machines, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068729), reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, financial metrics, or performance comparisons disclosed in the provided information. No positive or negative metrics are mentioned.

25-02-2026

UWM Holdings Corp filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, or other metrics are disclosed in the provided filing information.

25-02-2026

Lowe's Companies Inc filed an 8-K on February 25, 2026 (AccNo: 0000060667-26-000020), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This appears to be a multi-item, mandatory disclosure for earnings-related updates, with exhibits likely including press releases or statements.

25-02-2026

Pitney Bowes Inc. /DE/ filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068707, size: 174 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. No positive or negative performance indicators, scheduled events, or strategic details are mentioned.

25-02-2026

Reliance Global Group, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement terms, equity sales volume, or disclosures are provided. This is a multi-item mandatory filing with no quantitative impacts or period-over-period comparisons disclosed.

25-02-2026

Select Water Solutions, Inc. filed a Form 8-K on 2026-02-25 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or directional impacts are disclosed in the provided filing information. This is a multi-item filing likely including attachments given the 213 KB size.

25-02-2026

XPEL, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing description. This is a standard earnings-related disclosure without detailed financial data.

25-02-2026

XWELL, Inc. filed a Form 8-K on February 25, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals several corporate governance, financing, and structural changes, but specific details, transaction values, personnel involved, amendment contents, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are provided in the filing summary.

25-02-2026

Agassi Sports Entertainment Corp. filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of material non-public information with attached exhibits, but no specific events, transactions, metrics, or details are provided in the filing summary. No quantitative data, positive or negative performance indicators, or comparisons are disclosed.

25-02-2026

Enertopia Corp. filed a Form 8-K on February 25, 2026, reporting unregistered sales of equity securities under Item 3.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed in the filing summary. This multi-item filing highlights potential equity dilution but lacks specifics on size or terms.

25-02-2026

AMERICAN EXPRESS CO filed an 8-K on February 25, 2026 (AccNo: 0000004962-26-000107, Size: 185 KB) reporting under Item 7.01 Regulation FD Disclosure. No specific financial metrics, transactions, events, or quantitative data are detailed in the provided filing information. This appears to be a voluntary disclosure with no disclosed impacts on revenue, earnings, or operations.

25-02-2026

DevvStream Corp. filed an 8-K on February 25, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or strategic implications are mentioned.

25-02-2026

Totaligent, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, financial impacts, or other metrics are provided in the filing summary.

25-02-2026

Confluent, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing information related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts were provided in the available filing summary. This represents a standard SEC-required disclosure for potential material leadership or governance events.

25-02-2026

Capri Holdings Ltd filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer involved, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

25-02-2026

bioAffinity Technologies, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events, transactions, financial metrics, or exhibits provided in the available information. No quantitative data, positive or negative metrics, or directional implications are disclosed.

25-02-2026

IPG Photonics Corp filed a Form 8-K on February 25, 2026, under Item 8.01 Other Events. The filing has Accession Number 0001111928-26-000051 and a size of 225 KB. No specific details on the event, financial metrics, transactions, or quantitative data are disclosed.

25-02-2026

Permex Petroleum Corp filed an 8-K on 2026-02-25 disclosing a triggering event that accelerates or increases a direct financial obligation (Item 2.04), an officer change or director departure/election (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, title, reason for change, and financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

25-02-2026

Salarius Pharmaceuticals, Inc. filed an 8-K on February 25, 2026, specifically under Item 5.07 reporting Submission of Matters to a Vote of Security Holders, indicating results from a shareholder meeting. No specific proposals, vote outcomes, numerical tallies, or financial impacts are disclosed in the provided filing information. This is a standard post-meeting informational disclosure with no mentioned positive or negative developments.

25-02-2026

INTELLIGENT BIO SOLUTIONS INC. filed an 8-K on 2026-02-25 under Item 7.01 (Regulation FD Disclosure) to publicly disclose material nonpublic information and Item 9.01 (Financial Statements and Exhibits), indicating attached documents such as a press release or presentation. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are disclosed in the filing metadata. This is a multi-item, likely mandatory compliance filing for Reg FD with no directional financial impact evident.

25-02-2026

TJX COMPANIES INC /DE/ filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

25-02-2026

SOUTHERN CO filed an 8-K on 2026-02-25 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No details on transaction value, terms, parties, financial impact, or strategic context are disclosed.

25-02-2026

Chatham Lodging Trust filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the filing details provided. This appears to be a standard voluntary earnings-related disclosure with no quantified positive or negative performance indicators available.

25-02-2026

N2OFF, Inc. filed an 8-K on February 25, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, alongside Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transaction values, or impacts are disclosed in the filing summary. This multi-item filing appears informational with potential governance implications but lacks quantitative data or directional catalysts.

25-02-2026

Hovnanian Enterprises Inc filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were detailed. This is a multi-item informational filing with no quantified financial impacts provided.

25-02-2026

Frontera Group Inc. filed an 8-K on 2026-02-25 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also addresses departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers under Item 5.02. No financial terms, parties involved, deal structure, or quantitative metrics are disclosed.

25-02-2026

Eva Live Inc filed a Form 8-K on February 25, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the filing summary provided. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

25-02-2026

FIRST MID BANCSHARES, INC. filed a Form 8-K on February 25, 2026 (AccNo: 0001171843-26-001082, Size: 187 KB), reporting solely under Item 8.01 Other Events. No details on the core event, financial impacts, transaction values, or metrics are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or directional implications available.

25-02-2026

RANGE RESOURCES CORP filed an 8-K on February 25, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative details are provided in the filing summary. This appears to be a standard earnings-related disclosure, but all key performance indicators are NOT_DISCLOSED.

25-02-2026

Nukkleus Inc. filed a Form 8-K on 2026-02-25 disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, share counts, financial metrics, or impacts are disclosed in the provided filing summary. This multi-item filing signals potentially material developments, but lacks quantitative data for assessment.

25-02-2026

Bitcoin Infrastructure Acquisition Corp Ltd filed an 8-K on 2026-02-25 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), likely related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or quantitative data are disclosed in the provided filing summary. No positive, negative, or flat performance metrics are mentioned.

25-02-2026

SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information. This is a standard disclosure for financial results with no directional data available.

25-02-2026

Penumbra Inc filed a Form 8-K on February 25, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided information. No positive or negative financial changes can be assessed due to lack of quantitative data.

25-02-2026

Sky Century Investment, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or impacts are provided. No quantitative financial metrics, performance comparisons, or other material data are disclosed.

25-02-2026

Nevada Canyon Gold Corp. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or quantitative data are disclosed in the filing summary. This appears to be a voluntary informational disclosure without detailed content provided.

25-02-2026

Crescent Capital BDC, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. This is an informational filing on financial results without quantified data.

25-02-2026

Valmont Industries Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details including the officer's name, title, reason for change, and whether it is an appointment or departure are NOT_DISCLOSED.

25-02-2026

Eton Pharmaceuticals, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the filing summary. This appears to be an informational disclosure without quantified financial or operational metrics.

25-02-2026

QNB Corp. filed an 8-K on February 25, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are provided in the filing summary. This multi-item filing lacks quantitative metrics or directional indicators, resulting in no identifiable positive, negative, or flat performance data.

25-02-2026

Liberty Media Corp filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

25-02-2026

Nexalin Technology, Inc. filed an 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, or quantitative data are detailed in the provided filing information. This is a multi-item voluntary disclosure likely including attached exhibits such as a press release.

25-02-2026

MIDDLEFIELD BANC CORP filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, timing, or financial details are mentioned. No quantitative metrics, performance comparisons, or other impacts are provided.

25-02-2026

Greif, Inc. filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure, which typically involves voluntary sharing of material non-public information, and Item 9.01 Financial Statements and Exhibits, indicating attached materials. No specific financial metrics, transaction details, or performance data are disclosed in the filing summary. This appears to be a multi-item informational filing with no directional implications evident.

25-02-2026

PUBLIC CO MANAGEMENT CORP filed an 8-K on 2026-02-25 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the nature of the agreement, events, or any financial metrics. All quantitative data, transaction values, impacts, or scheduled events are NOT_DISCLOSED.

25-02-2026

AmBase Corp filed an 8-K on 2026-02-25 reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details on the agreement's parties, terms, value, or financial impacts provided. No quantitative metrics, comparisons, or scheduled events are disclosed.

25-02-2026

TriLinc Global Impact Fund LLC filed a Form 8-K on February 25, 2026, disclosing under Item 8.01 Other Events. No specific details of the event, transaction values, financial metrics, or quantitative data are mentioned. This is an informational filing with no disclosed positive or negative impacts.

25-02-2026

25-02-2026

SUN Communities Inc filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, positive or negative changes, or material events are explicitly stated in the provided filing information.

25-02-2026

Sarepta Therapeutics, Inc. filed an 8-K on February 25, 2026, under Item 2.02 reporting Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative details such as transaction values, percentages, or operational metrics are NOT_DISCLOSED.

25-02-2026

Metropolitan Bank Holding Corp. filed a Form 8-K on February 25, 2026 (AccNo: 0001104659-26-019661, Size: 229 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transactions, guidance, or other quantitative details are explicitly stated in the provided filing information. The disclosure appears informational without specified positive or negative impacts.

25-02-2026

C3.ai, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 2.05 for costs associated with exit or disposal activities, while Item 9.01 provides financial statements and exhibits. The filing combines earnings-related information with restructuring costs, indicating potential mixed financial performance. Specific revenue, earnings, cost amounts, or period-over-period changes are NOT_DISCLOSED.

25-02-2026

Kohl's Corp filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071564, Size: 158 KB), reporting under Item 8.01 'Other Events' and Item 9.01 'Financial Statements and Exhibits'. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure.

25-02-2026

Alector, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative financial data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance metrics.

25-02-2026

ST JOE Co filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019660, Size: 416 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing likely related to earnings release and attached exhibits.

25-02-2026

TKO Group Holdings, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071552), reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. This is a multi-item filing for financial results disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

25-02-2026

Encore Capital Group Inc filed an 8-K on February 25, 2026 (AccNo: 0001084961-26-000007, Size: 1 MB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing description. This is a standard voluntary disclosure of financial results without directional performance indicators.

• ·Sector: not specified
• ·Event Type: Financial Results
• ·Filed: 2026-02-25

25-02-2026

TWFG, Inc. filed an 8-K on 2026-02-25 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative details are disclosed.

• ·Multi-item 8-K filing (Items 2.02, 8.01, 9.01)
• ·AccNo: 0001628280-26-011644
• ·File size: 720 KB

25-02-2026

ZipRecruiter, Inc. filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 5.01 (Changes in Control of Registrant), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing addresses financial results alongside a change in control of the registrant, but no specific financial metrics, transaction details, or performance data are disclosed. No positive or negative quantitative changes are mentioned.

• ·AccNo: 0001617553-26-000015
• ·Filing size: 5 MB
• ·Event Type: Financial Results

25-02-2026

Red Robin Gourmet Burgers Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are mentioned in the provided filing details. This is a standard earnings-related disclosure with attached exhibits likely containing the detailed financial metrics.

• ·AccNo: 0001628280-26-011637
• ·Event Type: Financial Results
• ·Source: us_sec

25-02-2026

Schrodinger, Inc. filed an 8-K on 2026-02-25 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), with AccNo 0001490978-26-000009 and file size 406 KB. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other metrics are mentioned. No positive or negative performance details, period-over-period comparisons, or strategic updates are provided.

25-02-2026

Protagonist Therapeutics, Inc. filed an 8-K on February 25, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing summary. This is a standard earnings-related disclosure with no further details available.

25-02-2026

Trade Desk, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001671933-26-000009), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This multi-item filing signals an earnings release but lacks quantitative details for impact assessment.

25-02-2026

Zevia PBC filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative data are disclosed in the provided filing information.

25-02-2026

Arcus Biosciences, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, and Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

25-02-2026

NERDWALLET, INC. filed a Form 8-K on February 25, 2026 (AccNo: 0001625278-26-000012), reporting under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses financial results but no specific metrics, changes, or comparisons are detailed in the provided information. No positive or negative performance indicators, guidance, or events are mentioned.

25-02-2026

Veracyte, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

25-02-2026

Hamilton Beach Brands Holding Co filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

25-02-2026

Snowflake Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001628280-26-011631), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, balance sheet changes, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with attached exhibits.

25-02-2026

Chime Financial, Inc. filed a Form 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics were provided in the filing summary. This is a standard financial results disclosure with no detailed performance data available.

25-02-2026

agilon health, inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011630) disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for quarterly financial results announcements. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information.

25-02-2026

SkyWater Technology, Inc. filed a Form 8-K on 2026-02-25 (AccNo: 0001819974-26-000005, Size: 803 KB) disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related filing, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive or negative financial changes, balance sheet effects, or outlook revisions are detailed.

25-02-2026

Array Technologies, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001820721-26-000005), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard earnings-related disclosure with no specific revenue, earnings, or other financial metrics detailed in the provided filing information. No positive or negative performance indicators, guidance, or comparisons are disclosed.

25-02-2026

Safety Insurance Group Inc filed an 8-K on February 25, 2026 (AccNo: 0001172052-26-000002), reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed.

25-02-2026

SmartStop Self Storage REIT, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071534), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure without detailed performance data available.

25-02-2026

National Storage Affiliates Trust filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or period-over-period changes were disclosed in the provided filing details. This represents a standard voluntary disclosure of financial results with attached exhibits.

25-02-2026

Pure Storage, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with no detailed performance data available.

25-02-2026

Joby Aviation, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative financial metrics are available for analysis.

25-02-2026

KEWAUNEE SCIENTIFIC CORP /DE/ filed an 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the content of financial statements and exhibits are disclosed. This is a multi-item informational filing with no quantitative metrics or directional impacts provided.

25-02-2026

Barrett Business Services Inc filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071531), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet effects, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

25-02-2026

Zoom Communications, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with attached exhibits.

25-02-2026

Agilent Technologies, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing disclosing financial results with attached exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are detailed in the provided filing information.

25-02-2026

QT Imaging Holdings, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. The disclosure appears informational with no detailed positive or negative impacts mentioned.

25-02-2026

Energy Recovery, Inc. filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 2.05 (Costs Associated with Exit or Disposal Activities), and 2.06 (Material Impairments), with exhibits under Item 9.01. While results of operations are disclosed, the filing also reveals negative developments including material impairments and costs from exit or disposal activities. Specific financial metrics, impacts, or details are NOT_DISCLOSED.

25-02-2026

Sterling Infrastructure, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but specific revenue, earnings, margins, guidance, or period-over-period comparisons are NOT_DISCLOSED. No quantitative metrics or directional performance indicators (positive, negative, or flat) are provided in the filing details.

25-02-2026

Climb Global Solutions, Inc. filed an 8-K on 2026-02-25 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific financial metrics, revenue, earnings, guidance, or quantitative data are mentioned in the filing description. This is a multi-item filing typical for earnings announcements.

25-02-2026

Honest Company, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on the officer change, such as name, title, reason, or timing, are provided. No financial metrics, quantitative data, or performance comparisons are disclosed.

25-02-2026

BiomX Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, board impacts, or other governance details are mentioned.

25-02-2026

NIOCorp Developments Ltd filed a Form 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary. This is a multi-item filing with no disclosed transaction values, performance metrics, or directional implications.

• ·Multi-item 8-K filing (Items 1.01, 7.01, 8.01, 9.01)
• ·AccNo: 0001539497-26-000783, Size: 821 KB
• ·Sector: not specified

25-02-2026

BJ's Restaurants Inc filed an 8-K on 2026-02-25 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance data available.

• ·AccNo: 0001171843-26-001099
• ·Filing size: 421 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

AMERISAFE INC filed a Form 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics were mentioned, with all quantitative data NOT_DISCLOSED. No period-over-period comparisons, positive or negative performance indicators, or guidance changes were detailed in the filing excerpt.

25-02-2026

Soleno Therapeutics Inc filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071528), reporting under Item 2.02 Results of Operations and Financial Condition, and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were disclosed in the provided filing details. This appears to be a standard voluntary earnings disclosure with attached exhibits.

25-02-2026

Good Times Restaurants Inc. filed an 8-K on February 25, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders, typically indicating shareholder meeting results, and Item 8.01: Other Events. No specific vote outcomes, financial metrics, or details of other events are disclosed. No quantitative impacts or directional biases are evident from the available information.

25-02-2026

Dermata Therapeutics, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, titles, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or further implications are disclosed.

25-02-2026

PROCEPT BioRobotics Corp filed an 8-K on February 25, 2026 (AccNo: 0001588978-26-000002, Size: 419 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were detailed in the provided filing information. This represents a standard voluntary earnings-related disclosure with no positive or negative metrics reported.

25-02-2026

ARKO Petroleum Corp. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This multi-item filing represents a standard voluntary earnings-related disclosure. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.

25-02-2026

Hour Loop, Inc. filed an 8-K on 2026-02-25 disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

25-02-2026

IonQ, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071520), disclosing Results of Operations and Financial Condition under Item 2.02 along with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or quantitative financial metrics are mentioned in the provided filing summary. This appears to be a standard voluntary earnings-related disclosure without detailed performance data.

• ·Filing size: 871 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

25-02-2026

Revolution Medicines, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071517), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are mentioned in the provided filing information. No positive or negative performance indicators are disclosed.

25-02-2026

RxSight, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information.

25-02-2026

ARKO Corp. filed an 8-K on 2026-02-25 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the filing summary. This appears to be a standard earnings-related disclosure without detailed performance data provided.

25-02-2026

CARLSMED, INC. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This is an informational earnings-related disclosure without detailed performance data.

25-02-2026

Green Thumb Industries Inc. filed an 8-K on February 25, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet impacts, guidance, or quantitative metrics are disclosed in the provided filing details. This represents a standard voluntary earnings-related disclosure without detailed financial data.

25-02-2026

MARAVAI LIFESCIENCES HOLDINGS, INC. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure with no directional performance indicators available.

25-02-2026

Sinclair, Inc. filed a Form 8-K on 2026-02-25 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the filing summary. This is a standard earnings-related disclosure with no quantified financial impacts provided.

25-02-2026

Teladoc Health, Inc. filed a Form 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data points such as revenue, earnings, or balance sheet effects were disclosed in the provided filing information. This is a standard earnings-related disclosure with limited details available.

25-02-2026

Arcutis Biotherapeutics, Inc. filed an 8-K on February 25, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing details. This represents a standard voluntary earnings-related disclosure without quantified financial impacts.

25-02-2026

Mirum Pharmaceuticals, Inc. filed an 8-K on 2026-02-25 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, transaction values, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

25-02-2026

Dorman Products, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0000868780-26-000010), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits, indicating an announcement of financial results. No specific revenue, earnings, guidance, period-over-period changes, balance sheet impacts, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item informational filing with no detailed financial data available for analysis.

25-02-2026

Paramount Skydance Corp filed an 8-K on 2026-02-25 (AccNo: 0002041610-26-000008, Size: 1 MB) disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics were explicitly stated in the provided filing information. Sector not specified.

25-02-2026

CSB Bancorp, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071483, size 184 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the provided filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

25-02-2026

Sezzle Inc. filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, non-reliance on previously issued financial statements or related audit report under Item 4.02, and financial statements and exhibits under Item 9.01. The Item 4.02 disclosure signals potential material weaknesses or errors in prior reporting, which overshadows the routine earnings release in Item 2.02. No specific financial metrics, period-over-period changes, or guidance details are disclosed.

25-02-2026

Salesforce, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating an announcement of financial results with attached exhibits. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details.

25-02-2026

MYR Group Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative data are provided in the filing excerpt. This appears to be a standard earnings-related disclosure without detailed performance indicators.

25-02-2026

Marsh & McLennan Companies, Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are provided in the filing summary. This appears to be an informational disclosure with no additional positive or negative metrics mentioned.

25-02-2026

MiMedx Group, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive or negative financial changes can be assessed due to lack of extracted data.

25-02-2026

Carlyle Credit Income Fund filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative data were provided in the filing summary. This is a standard earnings-related disclosure without detailed performance indicators.

25-02-2026

Celldex Therapeutics, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.

25-02-2026

Xencor Inc filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data.

25-02-2026

Spok Holdings, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, transaction values, or guidance details are disclosed in the provided filing information. This multi-item filing indicates voluntary disclosure of earnings-related updates, but lacks quantitative data for impact assessment.

25-02-2026

DAILY JOURNAL CORP filed an 8-K on February 25, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders, indicating results from a shareholder meeting were disclosed. No specific proposals, voting outcomes, turnout percentages, or other numerical details are provided in the filing information. This appears to be a standard mandatory post-meeting disclosure with no financial or operational metrics mentioned.

25-02-2026

McGrath RentCorp filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071461), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure.

25-02-2026

Alexandria Real Estate Equities, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019662), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative details such as transaction value, terms, or financial impacts are provided in the filing summary.

25-02-2026

Park Dental Partners, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a standard earnings-related filing, but specific revenue, earnings, margins, period-over-period changes, or guidance are NOT_DISCLOSED. No positive or negative metrics, flat performance, or comparisons are provided in the excerpt.

25-02-2026

NWPX Infrastructure, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics were disclosed in the provided filing information. This appears to be a standard voluntary disclosure of financial results with attached exhibits.

25-02-2026

H2O AMERICA filed a Form 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were detailed in the provided filing information. This is a standard earnings-related disclosure without available performance data to assess positive, negative, or flat trends.

25-02-2026

BAB, INC. filed an 8-K on February 25, 2026 (AccNo: 0001437749-26-005604), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No specific details on the nature of the accountant change, reasons, prior or new auditor names, disagreements, financial impacts, or quantitative metrics are disclosed. This is a mandatory disclosure with potential implications for financial reporting integrity.

25-02-2026

MIAMI INTERNATIONAL HOLDINGS, INC. filed a Form 8-K on February 25, 2026 (AccNo: 0001438472-26-000017), reporting results of operations and financial condition under Item 2.02 and providing financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a voluntary earnings-related disclosure with attached exhibits.

• ·Sector: not specified
• ·Filing size: 4 MB
• ·Item 2.02 and 9.01 indicate multi-item filing focused on earnings release with exhibits

25-02-2026

CAPITAL SOUTHWEST CORP filed an 8-K on February 25, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing providing voluntary disclosure of material nonpublic information with attached exhibits; no specific transaction details, financial metrics, or directional impacts are disclosed.

25-02-2026

Cherry Hill Mortgage Investment Corp filed an 8-K on 2026-02-25 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

25-02-2026

Seadrill Ltd filed an 8-K on February 25, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the filing information provided. This appears to be a standard earnings-related disclosure without quantified data on revenue, earnings, or balance sheet impacts.

25-02-2026

ON24 INC. filed an 8-K on 2026-02-25 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits, indicating a financial results announcement. No specific revenue, earnings, guidance, or other metrics are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with attached exhibits.

25-02-2026

QXO, Inc. filed an 8-K on February 25, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, balance sheet changes, or period-over-period comparisons are disclosed in the filing excerpt. No positive, negative, or flat performance indicators are available.

25-02-2026

NORTHERN OIL & GAS, INC. filed an 8-K on February 25, 2026, under Item 2.02 reporting results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing summary. This is a standard multi-item earnings-related disclosure without quantified details.

25-02-2026

Magnite, Inc. filed an 8-K on February 25, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings release filing with no extracted positive or negative performance indicators.

25-02-2026

KRONOS WORLDWIDE INC filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), name, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

25-02-2026

Root, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001788882-26-000013), reporting under Item 2.02 for Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing summary. This appears to be a standard voluntary earnings disclosure without quantified metrics.

25-02-2026

Lifeward Ltd. filed a Form 8-K on February 25, 2026, disclosing unregistered sales of equity securities under Item 3.02 and other events under Item 8.01. No specific details such as transaction values, share counts, purchasers, financial impacts, or strategic context are provided. This is a multi-item filing with limited information available.

25-02-2026

Vyome Holdings, Inc. filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, or exhibits are provided in the filing summary. No financial metrics, positive or negative changes, or period-over-period comparisons are disclosed.

25-02-2026

Consolidated Edison Inc filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, quantitative metrics, positive or negative changes, or financial impacts are disclosed in the provided filing summary. This is a multi-item filing with no period-over-period comparisons or directional indicators available.

25-02-2026

Synopsys Inc filed a Form 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a standard disclosure of financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. This multi-item filing appears informational without detailed financial impacts.

25-02-2026

Veeco Instruments Inc filed a Form 8-K on February 25, 2026 (AccNo: 0001104659-26-019672), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing announcing financial results, but no specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided information. No positive, negative, or flat metrics are quantified.

25-02-2026

Generation Income Properties, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071590, Size: 383 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. This appears to be a single-item mandatory disclosure with no quantitative metrics, positive or negative changes, or period-over-period comparisons mentioned.

25-02-2026

Pathward Financial, Inc. filed an 8-K on February 25, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific proposals, vote counts, or outcomes are disclosed in the provided filing information. No financial metrics, changes, or other quantitative data mentioned.

25-02-2026

Enovix Corp filed an 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing information. This is a standard disclosure for financial results without quantified details.

25-02-2026

CBIZ, Inc. filed an 8-K on February 25, 2026 (AccNo: 0000944148-26-000035, Size: 1 MB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits furnished under Item 9.01. This is a multi-item filing focused on financial results, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are detailed in the provided information. No positive or negative performance indicators, segment details, or balance sheet effects are mentioned.

25-02-2026

TaskUs, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001829864-26-000005, Size: 566 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer involved, position affected, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED.

25-02-2026

SM Energy Co filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No period-over-period comparisons, positive or negative performance indicators, or transaction details are provided in the excerpt.

25-02-2026

OraSure Technologies Inc filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a quarterly financial results release. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. This is a multi-item filing typical for earnings announcements with no details on positive or negative performance available.

25-02-2026

Alkami Technology, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or transaction details were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data.

25-02-2026

Ibotta, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011669), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, or period-over-period metrics are explicitly stated in the provided filing details.

25-02-2026

OUTFRONT Media Inc. filed an 8-K on 2026-02-25 disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or other quantitative details are provided in the filing summary.

25-02-2026

CareDx, Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer involved, position affected, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

25-02-2026

POOL CORP filed an 8-K on February 25, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, guidance, or events are detailed in the provided filing summary. All quantitative data and event details are NOT_DISCLOSED.

25-02-2026

Nutanix, Inc. filed a Form 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing announces financial results alongside equity securities sales disclosures. No specific financial metrics, transaction values, performance changes, or period-over-period comparisons are disclosed.

25-02-2026

DigitalBridge Group, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed results excerpted.

25-02-2026

FirstSun Capital Bancorp filed a Form 8-K on February 25, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, financial metrics, transactions, or exhibits are provided in the filing summary. The disclosure appears informational with no quantified positive or negative impacts mentioned.

25-02-2026

Vista Gold Corp filed an 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no quantitative data or directional implications provided.

25-02-2026

Net Lease Office Properties filed a Form 8-K on 2026-02-25 disclosing under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with a document size of 7 MB (AccNo: 0001952976-26-000013). No specific financial metrics, transactions, or events are detailed in the filing metadata.

25-02-2026

FutureFuel Corp. filed an 8-K on February 25, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure with undetermined materiality.

25-02-2026

Barnwell Industries Inc filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's terms, parties, value, strategic rationale, or financial impacts are provided in the filing summary. This appears to be a multi-item mandatory disclosure with no quantitative metrics or period-over-period comparisons mentioned.

25-02-2026

Pursuit Attractions & Hospitality, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071572), reporting Results of Operations and Financial Condition under Item 2.02 and attaching Financial Statements and Exhibits under Item 9.01. This is a standard disclosure for financial results with no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics detailed in the provided filing information. No positive or negative financial changes were disclosed.

25-02-2026

Permian Resources Corp filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.

25-02-2026

First Foundation Inc. filed an 8-K on February 25, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction values, financial metrics, or exhibits are disclosed. This appears to be a multi-item informational filing with no quantitative impacts reported.

25-02-2026

ADMA Biologics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006781), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with results of operations and financial condition under Item 2.02. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason for change, financial metrics, or performance comparisons are disclosed.

• ·Filing size: 847 KB
• ·Event Type: Officer Change

25-02-2026

GoodRx Holdings, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics were disclosed in the filing summary. This appears to be an informational earnings-related disclosure without detailed performance data.

25-02-2026

LSB Industries, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071665), under Item 2.02 disclosing results of operations and financial condition as part of its financial results announcement. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing information. This is a single-item mandatory disclosure triggered by public dissemination of financial results, with sector not specified.

25-02-2026

Ethos Technologies Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071749), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard multi-item filing for financial results dissemination.

• ·File size: 320 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

Green Brick Partners, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011706), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period metrics are disclosed in the provided filing information. Sector is not specified.

25-02-2026

Ramaco Resources, Inc. filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing details. This is a multi-item filing typical for earnings releases, but detailed financial data is NOT_DISCLOSED.

25-02-2026

CrossAmerica Partners LP filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071725, Size: 8 MB), furnishing information under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing represents a voluntary disclosure of financial results, with no specific revenue, earnings, guidance, or period-over-period metrics provided in the summary. Detailed quantitative impacts or balance sheet effects are NOT_DISCLOSED.

25-02-2026

HCI Group, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be an earnings-related disclosure, but lacks detailed operational or financial data.

25-02-2026

Eagle Bancorp Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual, reason for change, or timing are disclosed.

25-02-2026

International Battery Metals Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071717), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data.

25-02-2026

Pennant Group, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing focused on financial results disclosure.

25-02-2026

Becton Dickinson & Co filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006794, Size: 542 KB), disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are provided in the filing summary. Critical information such as core event description, dollar values, or impacts is NOT_DISCLOSED.

25-02-2026

UNIVERSAL HEALTH REALTY INCOME TRUST filed an 8-K on 2026-02-25 under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or period-over-period comparisons were detailed in the provided filing summary. This is a standard financial results disclosure without quantified metrics.

25-02-2026

Churchill Downs Incorporated filed an 8-K on February 25, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with attached exhibits likely containing the press release.

25-02-2026

IMAX CORP filed an 8-K on 2026-02-25 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the filing summary. This is a standard earnings-related disclosure with no quantified positive or negative performance data provided.

• ·AccNo: 0001628280-26-011693
• ·File Size: 756 KB

25-02-2026

NPK International Inc. filed a Form 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics were mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with no directional performance indicators available.

25-02-2026

Kennedy-Wilson Holdings, Inc. filed an 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with no quantified metrics available.

25-02-2026

Catalyst Pharmaceuticals, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071702), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the Other Events, transaction values, financial metrics, or exhibits are disclosed. No positive or negative metrics are mentioned.

25-02-2026

Xperi Inc. filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or other quantitative metrics are mentioned in the filing description. This is a standard earnings-related disclosure with attached exhibits likely containing detailed financial data.

25-02-2026

StandardAero, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071686, Size: 1 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results disclosure, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are explicitly stated in the provided filing information. No positive or negative financial changes can be assessed due to lack of disclosed data.

25-02-2026

eHealth, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001333493-26-000007), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard voluntary earnings release filing.

25-02-2026

Hamilton Insurance Group, Ltd. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

25-02-2026

Global Net Lease, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019680, size 5 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure filing intended to share material nonpublic information and attach relevant exhibits. No specific financial metrics, transactions, guidance, or scheduled events are explicitly stated in the provided filing details.

25-02-2026

California Water Service Group filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details such as revenue, earnings, or balance sheet impacts are disclosed in the provided filing information. Critical financial data is missing, limiting assessment of performance.

25-02-2026

Marriott Vacations Worldwide Corp filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, period-over-period comparisons, or transaction values are mentioned.

25-02-2026

Xylem Inc. filed a Form 8-K on February 25, 2026, disclosing an unspecified other event under Item 8.01. No details on the nature of the event, financial metrics, transactions, or impacts are provided in the filing summary. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.

25-02-2026

ACADIA PHARMACEUTICALS INC filed an 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard financial results disclosure with no mentioned positive or negative performance indicators.

25-02-2026

Bristow Group Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001525221-26-000011, Size: 6 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics were provided in the filing details.

25-02-2026

Excelerate Energy, Inc. filed a Form 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, or other quantitative financial metrics were mentioned in the filing details provided. This appears to be a routine voluntary earnings disclosure with attached exhibits likely containing the detailed results.

25-02-2026

FTAI Aviation Ltd. filed an 8-K on February 25, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits (AccNo: 0001628280-26-011685, Size: 499 KB). No specific financial metrics, period-over-period comparisons, or quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without further elaboration.

25-02-2026

USA Compression Partners, LP filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or other quantitative data are disclosed in the provided filing information.

25-02-2026

EPR Properties filed a Form 8-K on February 25, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, guidance, or other quantitative metrics. No positive, negative, or flat performance indicators are detailed in the available information.

25-02-2026

Ecolab Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed in the provided information.

• ·Filing Accession Number: 0001104659-26-019742
• ·Filing size: 190 KB
• ·Event date: 2026-02-25

25-02-2026

LSI Industries Inc filed a Form 8-K on February 25, 2026 (AccNo: 0001437749-26-005618, Size: 9 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, events, or exhibits provided. No quantitative financial metrics, transaction values, or performance comparisons are disclosed.

25-02-2026

374Water Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details on the affected position, individual involved, reason for change, or timing are NOT_DISCLOSED. No quantitative data, governance impacts, or other metrics are mentioned.

25-02-2026

Crescent Energy Co filed a Form 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons were mentioned in the provided filing information. This is a standard earnings-related disclosure with no quantitative financial data provided.

25-02-2026

Seritage Growth Properties filed a Form 8-K on February 25, 2026, under Item 8.01 Other Events. No details on the specific event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or scheduled events mentioned.

25-02-2026

Avantor, Inc. filed a Form 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Specific details including the officer's name, title, reason for change, appointment or resignation status, and effective date are NOT_DISCLOSED.

25-02-2026

Interactive Strength, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 3.02 unregistered sales of equity securities, Item 5.03 amendments to articles of incorporation or bylaws or a change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing addressing material corporate governance and capital-related actions, but no quantitative details such as transaction sizes, share counts, financial impacts, or period-over-period comparisons are disclosed. No positive or negative financial metrics are provided, limiting assessment of performance variations.

25-02-2026

Service Properties Trust filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This represents a standard mandatory disclosure for financial results.

25-02-2026

Ingevity Corp filed an 8-K on 2026-02-25 under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

25-02-2026

DIEBOLD NIXDORF, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific names, titles, reasons for the change, effective dates, internal/external status, or quantitative details such as compensation amounts were disclosed in the provided filing information. No financial metrics, performance comparisons, or other material impacts were mentioned.

25-02-2026

OGE Energy Corp. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071800), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial impacts, or governance implications are provided.

25-02-2026

FS KKR Capital Corp filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed results available.

25-02-2026

Spring Valley Acquisition Corp. IV filed an 8-K on February 25, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or quantitative metrics are disclosed in the filing summary. Sector information is not specified.

25-02-2026

NVIDIA Corp filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a standard earnings-related disclosure with no specific quantitative metrics, comparisons, or guidance detailed in the provided filing information. No positive or negative performance indicators are mentioned.

25-02-2026

Starfighters Space, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing were disclosed.

25-02-2026

dMY Squared Technology Group, Inc. filed an 8-K on February 25, 2026, under Item 8.01 Other Events. No specific details regarding the event, financial impacts, transactions, or metrics are disclosed in the provided filing information.

25-02-2026

Synchrony Financial filed a Form 8-K on February 25, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the provided filing information. The filing size is 586 KB with Accession Number 0001193125-26-071785.

25-02-2026

Bimergen Energy Corp filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-008049), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, period-over-period comparisons, or quantitative impacts are disclosed in the provided filing summary. No positive or negative performance metrics are mentioned.

25-02-2026

Pebblebrook Hotel Trust filed an 8-K on February 25, 2026 (AccNo: 0001474098-26-000016), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results. No specific revenue, earnings, or other quantitative metrics were explicitly stated in the provided filing description.

25-02-2026

CHEMED CORP filed an 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

25-02-2026

Bit Digital, Inc. filed an 8-K on 2026-02-25 (AccNo: 0001213900-26-020401, Size: 264 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·AccNo: 0001213900-26-020401
• ·Event date: February 25, 2026
• ·Sector: NOT_DISCLOSED

25-02-2026

Whitestone REIT filed an 8-K on February 25, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified financial impacts.

25-02-2026

Montrose Environmental Group, Inc. filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative data are provided in the filing summary. This appears to be a standard earnings-related disclosure with no directional performance indicators mentioned.

25-02-2026

NeuroOne Medical Technologies Corp filed a Form 8-K on 2026-02-25 under Item 8.01 Other Events. No details on the specific event, transaction, financial metrics, or other quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.

25-02-2026

Contango ORE, Inc. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of potentially material nonpublic information with supporting exhibits attached. No financial metrics, transaction details, period-over-period comparisons, or scheduled events are disclosed.

25-02-2026

Ultra Clean Holdings, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0000950103-26-002636, Size: 222 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the nature of the other events or the content of any financial statements or exhibits. No quantitative metrics, transactions, positive or negative changes, or scheduled events are disclosed.

25-02-2026

Redwire Corp filed a Form 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), results of operations and financial condition (Item 2.02), and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with exhibits under Item 9.01. This multi-item filing indicates potential restructuring or refinancing activities alongside financial updates, but specific transaction details, dollar values, and performance metrics are NOT_DISCLOSED. No period-over-period comparisons, positive or negative metrics, or balanced performance data are provided.

25-02-2026

Fermi Inc. filed an 8-K on 2026-02-25 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

25-02-2026

UMH Properties, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, balance sheet metrics, or period-over-period comparisons are mentioned in the provided information. No positive or negative performance details, guidance changes, or quantitative impacts are available.

25-02-2026

PENTAIR plc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

• ·AccNo: 0000077360-26-000009
• ·Filing size: 197 KB
• ·Sector: not specified

25-02-2026

Neuronetics, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, effective dates, or quantitative compensation data are provided in the filing summary. This represents a standard SEC-required disclosure for material leadership events.

25-02-2026

CHESAPEAKE UTILITIES CORP filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, period-over-period comparisons, or material events with dollar values are mentioned.

25-02-2026

Crown Castle Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, timing, or any quantitative metrics are disclosed in the provided filing information.

25-02-2026

HCA Healthcare, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or any quantitative metrics are disclosed.

25-02-2026

Repay Holdings Corp filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071873), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or any quantitative data such as compensation amounts are NOT_DISCLOSED. No other financial metrics, board outcomes, or scheduled events are mentioned.

25-02-2026

LandBridge Co LLC filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative performance data were disclosed in the provided filing information. No positive, negative, or flat metrics were mentioned.

25-02-2026

Summit Hotel Properties, Inc. filed a Form 8-K on February 25, 2026, specifically under Item 9.01 for Financial Statements and Exhibits. The filing has Accession Number 0001497645-26-000017 and a size of 5 MB. No details on specific financial statements, exhibits, transactions, or metrics are disclosed in the provided filing summary.

• ·Accession Number: 0001497645-26-000017
• ·Filing source: us_sec
• ·Event Type: General Filing
• ·Sector: not specified

25-02-2026

Hartford Creative Group, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing where Item 8.01 voluntarily discloses a material other event, but specific details of the event or transaction are not provided in the filing summary. No quantitative financial metrics, period-over-period comparisons, or directional impacts are disclosed.

25-02-2026

Innoviva, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item, likely voluntary disclosure of earnings-related information.

25-02-2026

Global Medical REIT Inc. filed a multi-item 8-K on February 25, 2026, reporting results of operations and financial condition (Item 2.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific financial metrics, dollar values, period-over-period changes, or quantitative impacts are disclosed in the provided filing details. This filing provides informational disclosures without detailed performance data.

25-02-2026

Stellar Bancorp, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events or exhibits provided in the summary. No quantitative financial metrics, transactions, or directional impacts are disclosed.

25-02-2026

LeMaitre Vascular Inc filed an 8-K on 2026-02-25 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. All quantitative financial details remain NOT_DISCLOSED.

25-02-2026

Upland Software, Inc. filed an 8-K on February 25, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position, name, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, performance metrics, or scheduled events are mentioned.

25-02-2026

Darling Ingredients Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Specific details including officer names, positions, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

25-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are disclosed in the provided filing summary.

25-02-2026

NeoVolta Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

25-02-2026

LENSAR, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific transaction details, financial metrics, period-over-period comparisons, or quantitative data are disclosed in the filing summary. Analysis is limited to filing structure without content details.

25-02-2026

Houlihan Lokey, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information.

25-02-2026

APA Corp filed an 8-K on February 25, 2026 (AccNo: 0001841666-26-000012, Size: 913 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or quantitative metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without extracted numerical data.

• ·File Size: 913 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

Mueller Water Products, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with a document size of 6 MB, suggesting attachments such as press releases or presentations. No financial metrics, transactions, period-over-period comparisons, or quantitative data are explicitly stated.

25-02-2026

Motorsport Games Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impact, or other metrics are provided.

25-02-2026

Bath & Body Works, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, reasons, or timing are disclosed.

25-02-2026

Kodiak Gas Services, Inc. filed an 8-K on 2026-02-25 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed performance data available.

25-02-2026

PEDEVCO CORP filed an 8-K on 2026-02-25 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases, with no quantitative data available.

25-02-2026

Sealed Air Corp/DE filed an 8-K on February 25, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely disclosing shareholder meeting voting results and unspecified other events, with attached exhibits. No financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

25-02-2026

Weis Markets Inc filed an 8-K on February 25, 2026 (AccNo: 0000105418-26-000015, size 171 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or performance data are mentioned.

25-02-2026

LIGHTBRIDGE Corp filed an 8-K on February 25, 2026, pursuant to Item 2.02 announcing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure with all quantitative financial impacts NOT_DISCLOSED.

25-02-2026

urban-gro, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details on transaction terms, values, or impacts disclosed. No quantitative financial metrics, positive or negative changes, or period-over-period comparisons are mentioned.

25-02-2026

Tevogen Bio Holdings Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, names, reasons for changes, vote outcomes, or exhibits are disclosed.

25-02-2026

Exzeo Group, Inc. filed a Form 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. Sector details were not specified.

25-02-2026

Oceaneering International Inc. filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure. This represents a voluntary disclosure intended to comply with Regulation Fair Disclosure by broadly disseminating material nonpublic information. No financial metrics, transaction details, quantitative data, positive or negative changes, or operational updates were explicitly stated in the provided filing information.

25-02-2026

Soulpower Acquisition Corp. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 provides financial statements and exhibits. No quantitative metrics, deal terms, parties, or performance comparisons disclosed.

25-02-2026

YIJIA GROUP CORP. filed an 8-K on 2026-02-25 under Item 5.02 disclosing an officer change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative data, financial metrics, or other implications are mentioned.

25-02-2026

Premier Air Charter Holdings Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

25-02-2026

MARA Holdings, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or terms are disclosed.

25-02-2026

Manhattan Bridge Capital, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's terms, parties, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

• ·Filing Accession Number: 0001493152-26-008061
• ·Filing size: 321 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

DIRTT Environmental Solutions Ltd filed an 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue figures, earnings, comparisons, or other quantitative data are disclosed in the provided filing information. This is a standard disclosure for financial results with no details on performance direction.

25-02-2026

TETRA TECHNOLOGIES INC filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned in the provided filing summary. This is a standard informational disclosure for financial results with no quantified data available.

25-02-2026

HEICO CORP filed an 8-K on February 25, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed results available.

25-02-2026

SEACOR Marine Holdings Inc. filed a Form 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results, but no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics were disclosed in the provided information. No positive or negative financial changes were detailed.

25-02-2026

ClearSign Technologies Corp filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019768), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific revenue, earnings, balance sheet metrics, guidance, or period-over-period comparisons are disclosed in the provided filing information.

25-02-2026

Avalon GloboCare Corp. filed a Form 8-K on February 25, 2026, disclosing multiple events under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, financial impacts, named parties, or quantitative details were provided in the filing summary. This multi-item filing signals potential strategic, financial, and governance changes, but lacks disclosure on directionality or magnitude.

25-02-2026

Solstice Advanced Materials Inc. filed an 8-K on 2026-02-25 reporting under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific details on individuals, reasons, effective dates, or financial terms are provided in the filing summary.

25-02-2026

Armada Acquisition Corp. III filed an 8-K on 2026-02-25 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) in connection with a merger/acquisition event. No specific details on parties, deal structure, valuation, financial metrics, or performance comparisons are disclosed in the provided filing summary. All quantitative and qualitative transaction information remains NOT_DISCLOSED.

25-02-2026

Chord Energy Corp filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with attached exhibits.

25-02-2026

Vishay Intertechnology Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected officer, position, appointment or resignation status, reasons, and timing are NOT_DISCLOSED.

25-02-2026

Ideal Power Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory and voluntary disclosure with no specific transaction details, dollar values, share counts, financial impacts, or strategic context provided in the filing summary. No positive or negative metrics, period-over-period changes, or guidance revisions are disclosed.

25-02-2026

25-02-2026

Flotek Industries Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative financial metrics were disclosed.

25-02-2026

Catalyst Crew Technologies Corp. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The transaction triggered changes in control of the registrant (Item 5.01), departure or election of directors and officers with compensatory arrangements (Item 5.02), a change in shell company status (Item 5.06), and unregistered sales of equity securities (Item 3.02). No financial terms, parties involved, valuations, or quantitative metrics were disclosed.

25-02-2026

DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.